Tuesday 24 May
Changing face of atherosclerosis
- Wouter Jukema
- Alberto Zambon
Alberto ZambonPadova, Italy
Professor Alberto Zambon received his MD degree in 1988 from the University of Padua. He is board certified in endocrinology and metabolism (1993), and holds a PhD in gerontology from the University of Padua (1998).
Professor Zambon was a Post-Doctoral Fellow in Endocrinology and Metabolism at the Division of Endocrinology, Metabolism and Nutrition, School of Medicine, University of Washington, Seattle, (1991-1993 and again 1995-1998), where, in 1999, he was appointed Acting Assistant Professor of Medicine and currently holds a position of Affiliate Assistant Professor of Medicine.
Professor Zambon received an AHA fellowship award (1996-97), the 1997 Young Faculty Award of the Western Society for Clinical Investigation (US), the Paul Beeson Physician Faculty Scholarship of American Federation For Aging Research (1998-2001), the Merck Young Investigators on Lipid Research Award for outstanding research contribution (1999) and the Award for Outstanding Scientific Contributions in Medical Research (2000 and 2001) from the School of Medicine, University of Padua, Italy. His main clinical interests are in the care of patients with premature atherosclerosis and in patients with lipid disorders. Professor Zambon is currently a member of the national board of the Italian Atherosclerosis Society Foundation. He is a member of the Italian Atherosclerosis Society (SISA), the European Atherosclerosis Society (EAS), Gold Heart Member of the AHA and FAHA, and the International Atherosclerosis Society (IAS). He has served as member of the the International Advisory Board for the XV and XVI International Atherosclerosis Society (IAS) Symposiums. Professor Zambon is currently a member of the Executive Board of the EAS.
Filippo Crea, Rome, Italy
Filippo Crea is Professor of Cardiology, Director of the Department of Cardiovascular Sciences, Director of the Postgraduate School in Cardiology and Coordinator of the PhD program in Cellular and Molecular Cardiology at the Catholic University in Rome, Italy.
His research activity has primarily focused on studying the multiple mechanisms of myocardial ischaemia in chronic and acute coronary syndromes (ACS). Professor Crea has received numerous research awards including the Arrigo Recordati International Prize for the “Lifetime achievement in researching the pivotal role of microcirculation in systemic and organ diseases”.
He has given prestigious lectureship worldwide including the 7th annual Robert L. Krakoff International Lecture in Cardiovascular Medicine at the Brigham and Women’s Hospital, Harvard University Medical School. He is Editor-in-Chief of the European Heart Journal since September 2020.
Peter Libby, Boston, USA
Peter Libby, MD, is a cardiovascular specialist at Brigham and Women’s Hospital in Boston, Massachusetts, and holds the Mallinckrodt Professorship of Medicine at Harvard Medical School. His areas of clinical expertise include general and preventive cardiology. His current major research focus is the role of inflammation in vascular diseases such as atherosclerosis. Dr. Libby has a particular devotion to translate his basic laboratory studies to pilot and then large-scale clinical cardiovascular outcome trials. He instigated and helped to lead the large-scale CANTOS trial that provided clinical validation of the role of inflammation in atherosclerosis.
An author and lecturer on cardiovascular medicine and atherosclerosis, Dr. Libby has published extensively in top ranked medical journals. He is the Editor-in Chief for the 12th edition of Braunwald’s Heart Disease
Dr. Libby earned his medical degree at the University of California, San Diego, and completed his training in internal medicine and cardiology at the Peter Bent Brigham Hospital (now Brigham and Women’s Hospital). He also holds an honorary MA degree from Harvard University, and Doctorat honoris causa from the Université de Lille, France , Université Laval in Québec, Canada, and Doctor Medicinæ Honoris Causa degree from Goethe University, Frankfurt am Main, Germany
Julie Redfern, Westmead, Australia
Julie Redfern is a Professor of Public Health and the Research Academic Director (Researcher Development Output and Impact) in the Faculty of Medicine and Health, University of Sydney; a practicing Physiotherapist; and Professorial Fellow at The George Institute for Global Health. She has been a Chief Investigator on research grants totalling $25M in the past 5 years and has published over 190 manuscripts and 4 book chapters. Professor Redfern has held continuous research fellowships from the National Health and Medical Research Council (Australia) and the National Heart Foundation of Australia. She has over15 years of experience developing, testing and implementing scalable strategies to close evidence-practice gaps and improve health outcomes for people with chronic disease. Professor Redfern also has expertise in multidisciplinary and translational research and is an advocate for effective secondary prevention of cardiovascular disease. Professor Redfern currently holds a NHMRC Career Development Fellowship (Investigator Grant Leadership Level 2 commencing in 2022, $AU2.9M) and is CIA on a NHMRC Synergy Grant (SOLVE-CHD, $AU5M). She is Co-Chair of the Clinical and Preventative Cardiology Council of the Cardiac Society of Australia and New Zealand.
Brian Ference, Cambridge, United Kingdom